These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9049387

  • 1. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.
    Zerfass K, Levy LM, Cremonesi C, Ciccolini F, Jansen-Dürr P, Crawford L, Ralston R, Tommasino M.
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1815-20. PubMed ID: 9049387
    [Abstract] [Full Text] [Related]

  • 2. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
    Pagano M, Dürst M, Joswig S, Draetta G, Jansen-Dürr P.
    Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
    Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR.
    Proc Natl Acad Sci U S A; 1992 May 15; 89(10):4549-53. PubMed ID: 1316611
    [Abstract] [Full Text] [Related]

  • 4. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC, DiMaio D.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12513-8. PubMed ID: 11070078
    [Abstract] [Full Text] [Related]

  • 5. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
    Arroyo M, Bagchi S, Raychaudhuri P.
    Mol Cell Biol; 1993 Oct 07; 13(10):6537-46. PubMed ID: 8413252
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.
    Katich SC, Zerfass-Thome K, Hoffmann I.
    Oncogene; 2001 Feb 01; 20(5):543-50. PubMed ID: 11313986
    [Abstract] [Full Text] [Related]

  • 7. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Cao L, Faha B, Dembski M, Tsai LH, Harlow E, Dyson N.
    Nature; 1992 Jan 09; 355(6356):176-9. PubMed ID: 1530885
    [Abstract] [Full Text] [Related]

  • 8. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ, Roman A.
    Virology; 1997 Dec 08; 239(1):238-46. PubMed ID: 9426463
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
    Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA.
    Genes Dev; 1993 Dec 08; 7(12A):2392-404. PubMed ID: 8253385
    [Abstract] [Full Text] [Related]

  • 10. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
    Fattaey AR, Harlow E, Helin K.
    Mol Cell Biol; 1993 Dec 08; 13(12):7267-77. PubMed ID: 8246949
    [Abstract] [Full Text] [Related]

  • 11. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM, Russo P, Venta-Perez G, Cordon-Cardo C, Rifkind RA, Marks PA.
    Cancer Res; 1997 Jul 01; 57(13):2789-98. PubMed ID: 9205091
    [Abstract] [Full Text] [Related]

  • 12. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
    Lam EW, Morris JD, Davies R, Crook T, Watson RJ, Vousden KH.
    EMBO J; 1994 Feb 15; 13(4):871-8. PubMed ID: 8112300
    [Abstract] [Full Text] [Related]

  • 13. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M, Gill RM, Hamel PA.
    Cell Growth Differ; 1995 Oct 15; 6(10):1287-98. PubMed ID: 8845306
    [Abstract] [Full Text] [Related]

  • 14. Functional studies of E7 proteins from different HPV types.
    Ciccolini F, Di Pasquale G, Carlotti F, Crawford L, Tommasino M.
    Oncogene; 1994 Sep 15; 9(9):2633-8. PubMed ID: 8058327
    [Abstract] [Full Text] [Related]

  • 15. Interaction of mouse adenovirus type 1 early region 1A protein with cellular proteins pRb and p107.
    Smith K, Ying B, Ball AO, Beard CW, Spindler KR.
    Virology; 1996 Oct 01; 224(1):184-97. PubMed ID: 8862413
    [Abstract] [Full Text] [Related]

  • 16. Characterization of an E2F-p130 complex formed during growth arrest.
    Corbeil HB, Branton PE.
    Oncogene; 1997 Aug 07; 15(6):657-68. PubMed ID: 9264406
    [Abstract] [Full Text] [Related]

  • 17. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ, Schaley JE, Feeney G, Hearing P.
    Oncogene; 2001 Apr 05; 20(15):1882-91. PubMed ID: 11313936
    [Abstract] [Full Text] [Related]

  • 18. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA, Rhodes N, Paules RS, Mudryj M.
    Oncogene; 1997 Jun 26; 14(25):3029-38. PubMed ID: 9223666
    [Abstract] [Full Text] [Related]

  • 19. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
    Huang PS, Patrick DR, Edwards G, Goodhart PJ, Huber HE, Miles L, Garsky VM, Oliff A, Heimbrook DC.
    Mol Cell Biol; 1993 Feb 26; 13(2):953-60. PubMed ID: 7678696
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional repression by the Rb-related protein p107.
    Zamanian M, La Thangue NB.
    Mol Biol Cell; 1993 Apr 26; 4(4):389-96. PubMed ID: 7685208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.